Although the main role of CD8+ T cells has been outlined once HIV infection is established, some studies reported the presence of HIV-specific CD8+ T cells in HESNs with high effector capacity, suggesting that these cells could also be implicated in avoiding the establishment of the infection and that they could be crucial for the development of a successful preventive vaccine (104–106). Here, CD8A is linked to HIV infectious disease.